Spark Therapeutics, Inc. (ONCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Spark Therapeutics, Inc. (ONCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Spark Therapeutics, Inc. (ONCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Spark Therapeutics, Inc. (ONCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
40 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Spark Therapeutics, Inc. (Spark) is a pharmaceutical company that develops gene therapy products for the treatment of debilitating genetic diseases such as inherited retinal dystrophies, hematologic disorders and neurodegenerative diseases. The companys gene therapy vectors used in its programs are engineered using an adeno-associated virus, which is a small, non-pathogenic virus. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1. Sparks SPK-RPE65 is intentended to cure rare blinding conditions caused by mutations in the RPE65 gene. The company collaborates with pharma and biotech companies for its research and development activities.

Spark Therapeutics, Inc. (ONCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which hav

  
Source:
Document ID
GDPH500663D
Country
Industry
Ticker
ONCE=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Spark Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Spark Therapeutics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Spark Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Spark Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Spark Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Spark Therapeutics, Inc., Pharmaceuticals &Healthcare, Deal Details1126
  Venture Financing111
    Spark Therapeutics Raises USD73 Million in Series B Financing112
    Spark Therapeutics Raises US$50 Million In Venture Financing131
    Genable Technologies Secures US$6.8 Million In Series B Financing142
  Partnerships161
    Spark Therapeutics Enters into Co-Development Agreement with Pfizer161
  Licensing Agreements171
    Spark Therapeutics Enters into Option Agreement with Clearside Biomedical to License Gene Therapy171
    Spark Therapeutics Enters Into Licensing Agreement With Genable Technologies182
    Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania for Proviral Plasmids202
    Spark Therapeutics Enters into Licensing Agreement with University of Iowa Research Foundation222
    Spark Therapeutics Enters into Licensing Agreement with Children s Hospital of Philadelphia242
    Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania262
    Benitec Biopharma Enters Into Licensing Agreement With Genable Technologies281
  Equity Offering291
    Spark Therapeutics Raises USD181 Million in Public Offering of Shares292
    Spark Therapeutics Prices Public Offering of Shares for USD94 Million312
    Spark Therapeutics Raises USD185 Million in IPO332
  Acquisition351
    Spark Therapeutics Acquires Genable Technologies for USD15.2 Million352
Spark Therapeutics, Inc. - Key Competitors371
Key Employees381
Locations And Subsidiaries391
  Head Office391
  Other Locations &Subsidiaries391
Appendix401
  Methodology401
  About GlobalData401
  Contact Us401
  Disclaimer401

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Spark Therapeutics, Inc. (ONCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Spark-Therapeutics-Inc-ONCE-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24973>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Spark Therapeutics, Inc. (ONCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Spark-Therapeutics-Inc-ONCE-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24973>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research